possible new osteoporosis med

Lila de Tantillo Health Guide
  • The FDA has given conditional approval for a new drug, bazedoxefene, which would be sold as Viviant if approved. It's a SERM (selective estrogen receptor modulator), the class of drugs that includes Evista. The company is Wyeth; let's see how long it takes to get it out to market.
    Add This Infographic to Your Website or Blog With This Code:
Published On: April 26, 2007